High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia

International Journal of Geriatric Psychiatry

Volumn 22, Issue 4, 2007, Pages 305-311

  Zuliani, G ^a   Guerra, G ^a   Ranzini, M ^a   Rossi, L ^a   Munari, M R ^b   Zurlo, A ^c   Ble A ^a   Volpato, S ^a   Atti, A R ^a   Fellin, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b CA FONCELLO HOSPITAL   (Italy)

^c S ANNA HOSPITAL   (Italy)

Author keywords

Cytokines; Dementia; Disability; Funtional status; Interleukin 6

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BARTHEL INDEX; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; HYPERTENSION; INDEPENDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; MULTIPLE REGRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEX DIFFERENCE; STROKE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; DISABILITY EVALUATION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; STATISTICS AS TOPIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247610882     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1674     Document Type: Article

References (23)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.
2. Blasko I, Grubeck-Loebenstein B. 2003. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging 20(2): 101-113.
3. Cesari M, Penninx BW, Pahor M, et al. 2004. Inflammatory markers and physical performance in older persons: the InChianti study. J Gerontol Med Sci 59A: 242-248.
4. Cohen HJ, Pieper CF, Harris T, et al. 1997. The Association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol Med Sci 52: M201-M208.
5. Colbert LH, Visser M, Simonsick EM, et al. 2004. Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. J Am Geriatr Soc 52: 1098-1104.
6. Erkinjuntti T, Roman G, Gauthier S. 2004. Treatment of vascular dementia: evidence from clinical trials with cholinesterase inhibitors. Neurol Sci 15(226): 63-66.
7. Ferrucci L, Penninx BW, Volpato S, et al. 2002. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50(12): 1947-1954.
8. Fratiglioni L, Grut M, Forsell Y, et al. 1991. Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology 41: 1886-1892.
9. Fried LP, Guralnik JM. 1997. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 45: 92-100.
10. Gauthier SG. 2005. Alzheimer's disease: the benefits of early treatment. Eur J Neurol 12(Suppl. 3): 11-16.
11. Hofman A, Ott A, Breteler MM, et al. 1997. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer disease in the Rotterdam Study. Lancet 349: 151-154.
12. Krabbe KS, Pedersen M, Bruunsgaard H. 2004. Inflammatory mediators in the elderly. Exp Gerontology 39: 687-699.
13. Lim PP, Sahadevan S, Choo GK, Anthony P. 1999. Burden of caregiving in mild to moderate dementia: an Asian experience. Int Psychogeriatr 11: 411-420.
14. Mahoney FI, Barthel DW. 1965. Functional Evaluation: the Barthel Index. State Med J 14: 61-65.
15. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
16. Ott A, Breteler MMB, van Harskamp F, et al. 1995. Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study. BMJ 310: 970-973.
17. Penninx BW, Pahor M, Cesari M, et al. 2004a. Anemia is associated with disability and decreased physical performance and muscle strenght in the elderly. J Am Geriatr Soc 52: 719-724.
18. Penninx BW, Kritchevski SB, Newman AB, et al. 2004b. Inflammatory markers and indicent mobility limitation in the elderly. J Am Geriatr Soc 52: 1105-1113.
19. Roman GC, Tatemichi TK, Erkinjunnti T, et al. 1993. Vascular dementia: diagnostic criteria for research study. Neurology 43: 250-260.
20. Siew CW, Ho HK, Cheong SK, et al. 2003. Caregiver stress in activities of daily living-dependent elderly aged more than 65 years. Ann Acad Med Singapore 32: S69-S71.
21. Thomas VS. 2001. Excess functional disability among demented subjects? Findings from the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 12(3): 206-210.
22. Visser M, Pahor M, Taaffe DR, et al. 2002. Relationship of interleukin-6 and tumor necrosis factor α with muscle mass and muscle strenght in elderly men and women: the health ABC study. J Gerontol Med Sci 57: M326-M332.
23. Waterer GW, Kritchevski SB, Bauer DC, et al. 2001. Interleukin-6, cigarette smoking, airway obstruction and respiratory sympmtoms in the well-functioning elderly. Resp Crit Care Med 163: A349.